Sponsor

Catharina Ziekenhuis Eindhoven

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Catharina Ziekenhuis Eindhoven appears in 21 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials21
Recruiting shown3
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

21 shown
Implementation of Up-front ctDNA Into Lung Cancer Care and Development of Liquid Biopsy-based Decision Support Models - LM² StudyNCT06105177 · lead sponsor · 2023-10-31
RECRUITING
Sleep Evaluation Before and After Metabolic SurgeryNCT07693491 · lead sponsor · 2026-09-01
NOT_YET_RECRUITING
Clinical Validation of Algorithms for Mean Systemic Filling Pressure and Automated Cardiac OutputNCT04202432 · lead sponsor · 2019-06-24
COMPLETED
Mind Our Heart StudyNCT03826836 · lead sponsor · 2019-01-01
UNKNOWN
Assessing the Value of eHealth for Bariatric SurgeryNCT03394638 · lead sponsor · 2017-02-21
UNKNOWN
Nutritional Route In Esophageal Resection Trial IINCT02378948 · lead sponsor · 2015-10-01
COMPLETED
Mean Systemic Filling Pressure Continuous Diuretics Critical Care PatientsNCT03395951 · lead sponsor · 2014-10-01
COMPLETED
Intrathoracic Bloodvolume Measurement by Contrast Enhanced Ultrasound: Validation of the Technique and Evaluation as a Measurement of Response to Cardiac Resynchronization Therapy: a Pilot StudyNCT01735838 · lead sponsor · 2012-06-01
COMPLETED
Endocardial Pacing in On-table Non-responders in Cardiac Resynchronization TherapyNCT01193712 · lead sponsor · 2010-08-01
WITHDRAWN
Chronic Obstructive Pulmonary Disease (COPD) and OsteoporosisNCT01067248 · lead sponsor · 2010-01-01
COMPLETED
Case Control Study: Determinants of Osteoporosis in GOLD II COPD Patients.NCT00725673 · lead sponsor · 2007-09-01
COMPLETED
Clinical Usefulness and Efficacy of Intrathoracic Impedance Monitoring Using the OptiVol Patient Alert(TM)NCT00488501 · lead sponsor · 2007-07-01
COMPLETED
Liposomal Doxorubicin and Docetaxel in HER2 Negative Metastatic Breast CancerNCT00377559 · lead sponsor · 2006-05-01
COMPLETED
Osteoporosis and Chronic Obstructive Pulmonary Disease (COPD)NCT00231127 · lead sponsor · 2005-04-01
COMPLETED
Lymphatic Mapping After Previous Breast SurgeryNCT01164748 · lead sponsor
COMPLETED
Detection of Minimal Residual Disease Post-prostatectomyNCT07334275 · collaborator · 2025-09-16
RECRUITING
Supplemental Screening for Women With Extremely Dense Breast Tissue: the DENSE-2 TrialNCT06636370 · collaborator · 2024-11-11
RECRUITING
Investigating the Impact of Nudging Cardiologists to Prescribe Guideline-directed Medical Therapy in Heart Failure PatientsNCT06844006 · collaborator · 2024-06-13
ENROLLING_BY_INVITATION
The QUILT Study: Quilting Sutures in Patients Undergoing Breast Cancer SurgeryNCT05272904 · collaborator · 2022-08-01
UNKNOWN
Defining the Potency of DTG/3TC for Suppressed HIV Patients in Real-life: the DUALING StudyNCT04707326 · collaborator · 2019-11-01
ACTIVE_NOT_RECRUITING
Accuracy of Lymph Node Imaging in Prostate Cancer: PSMA PET-CT and Nano-MRINCT03223064 · collaborator · 2016-12-30
UNKNOWN

Drugs studied in this sponsor's trials

0 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Catharina Ziekenhuis Eindhoven as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

No mapped drug interventions are published for this sponsor's trials. This does not mean the studies contain no drug interventions: some registry names have not been mapped to RxNorm.

Sponsor roles

lead sponsor15
collaborator6
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.